1 |
BATCHELOR T T. Primary central nervous system lymphoma: a curable disease[J]. Hematol Oncol, 2019, 37(): 15-18.
|
2 |
NOCTURNE G, PONTARINI E, BOMBARDIERI M,et al. Lymphomas complicating primary Sjögren’s syndrome: from autoimmunity to lymphoma[J]. Rheumatology (Oxford), 2019, 60(8): 3513-3521.
|
3 |
RETAMOZO S, BRITO-ZERÓN P, RAMOS-CASALS M. Prognostic markers of lymphoma development in primary Sjögren syndrome[J]. Lupus, 2019, 28(8): 923-936.
|
4 |
TATEISHI K, MIYAKE Y, NAKAMURA T, et al. Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development[J]. Brain Tumor Pathol, 2021, 38(3): 173-182.
|
5 |
MAHALE P, HERR M M, ENGELS E A, et al. Autoimmune conditions and primary central nervous system lymphoma risk among older adults[J]. Br J Haematol, 2020, 188(4): 516-521.
|
6 |
RISCHMUELLER M, TIEU J, LESTER S. Primary Sjögren’s syndrome[J].Best Pract Res Clin Rheumatol, 2016, 30(1): 189-220.
|
7 |
STEFANSKI A L, TOMIAK C, PLEYER U, et al. The diagnosis and treatment of Sjögren’s syndrome[J]. Dtsch Arztebl Int, 2017, 114(20): 354-361.
|
8 |
SAKAIRI T, NAKASATOMI M, WATANABE M, et al. Primary central nervous system lymphoma in a patient with neuropsychiatric systemic lupus erythematosus receiving mycophenolate mofetil: a case report and literature review[J]. Mod Rheumatol Case Rep, 2022, 6(1): 36-40.
|
9 |
BAECKLUND E, SMEDBY K E, SUTTON L A,et al.Lymphoma development in patients with autoimmune and inflammatory disorders: what are the driving forces? [J]. Semin Cancer Biol, 2014, 24: 61-70.
|
10 |
BAKCHINE S, DUYCKAERTS C, HASSINE L,et al.Central and peripheral neurologic lesions in primary Gougerot-Sjögren syndrome. Clinicopathological study of a case[J].Rev Neurol (Paris),1991,147(5):368-375.
|
11 |
FAN G H, DAI F, CHEN S J, et al. Neurological involvement in patients with primary Sjögren’s syndrome[J]. J Clin Rheumatol, 2021, 27(2): 50-55.
|
12 |
肖秋凤, 费允云. 原发性胆汁性胆管炎与干燥综合征的关系[J].临床肝胆病杂志,2021,37(10): 2262-2268.
|
13 |
ARGYROPOULOU O D, TZIOUFAS A G. Common and rare forms of vasculitis associated with Sjögren’s syndrome[J].Curr Opin Rheumatol,2020,32(1): 21-28.
|
14 |
VISCO C, TANASI I, QUAGLIA F M, et al. Oncogenic mutations of MYD88 and CD79B in diffuse large B-cell lymphoma and implications for clinical practice[J]. Cancers (Basel), 2020, 12(10): E2913.
|
15 |
THURNER L, PREUSS K D, BEWARDER M, et al. Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma[J]. Blood, 2018, 132(26): 2744-2753.
|
16 |
蔡 青, 魏一鸣, 阮 航, 等. 外周血淋巴细胞绝对数对初诊治原发性中枢神经系统淋巴瘤预后评估的价值[J]. 郑州大学学报(医学版), 2021,56(4): 576-580.
|
17 |
ITOH T, SHIMIZU M, KITAMI K, et al. Primary extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type in the CNS[J]. Neuropathology, 2001, 21(3): 174-180.
|
18 |
KHANNA D, VINTERS H V, BRAHN E. Angiocentric T cell lymphoma of the central nervous system in a patient with Sjögren’s syndrome[J]. J Rheumatol, 2002, 29(7): 1548-1550.
|
19 |
BIRD C E, TRAYLOR J I, THOMAS J, et al. Primary peripheral T-cell central nervous system lymphoma[J]. Surg Neurol Int, 2021, 12: 465.
|
20 |
KINIKLI G, ERTEN S, TANJU S, et al. Central nervous system lymphoma in a patient with Sjogren’s syndrome and autoimmune thyroiditis (Hashimoto’s thyroiditis)[J]. Clin Rheumatol, 2007, 26(8):1377-1379.
|
21 |
姜季委, 林梅青, 马 兰, 等. 原发性中枢神经系统淋巴瘤合并干燥综合征和自身免疫性甲状腺炎一例[J]. 中华医学杂志, 2018, 98(33): 2686-2687.
|
22 |
TARELLA C, GUELI A, RUELLA M, et al. Lymphocyte transformation and autoimmune disorders[J]. Autoimmun Rev, 2013, 12(8): 802-813.
|
23 |
NOCTURNE G, VIRONE A, NG W F, et al. Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjögren’s syndrome[J].Arthritis Rheumatol,2016,68(4):977-985.
|